Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-07

Clinical Trial Update: Effects of Vitamin D in Parkinson's Disease (PD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of Vitamin D on Parkinson disease and fall risk; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson Disease, Accidental Falls | Phase 2 | Status: COMPLETED | Results posted: 2016-03-07